Robotic surgery for primary head and neck squamous cell carcinoma of unknown site

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 11, 2013, Pages 1203-1211

  Patel, Sapna A ^a   Magnuson, J Scott ^b,c   Holsinger, F Christopher ^d   Karni, Ron J ^e   Richmon, Jeremy D ^f   Gross, Neil D ^g   Bhrany, Amit D ^a   Ferrell, Jay K ^e   Ford, Samuel E ^h   Kennedy, Aimee A ⁱ   Méndez, Eduardo ^a,j  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Celebration Hospital   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j USA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EAR NOSE THROAT SURGERY; ECHOGRAPHY; FEMALE; FOLLOW UP; GLOSSECTOMY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN SITE; HUMAN; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PALATINE TONSIL; PAPILLOMAVIRUS INFECTION; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; ROBOTICS; TONGUE SWELLING; TONSILLECTOMY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH; NATURAL ORIFICE ENDOSCOPIC SURGERY; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES; ROBOTICS; TREATMENT OUTCOME;

EID: 84892422690     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.5189     Document Type: Article

References (41)

1. Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev. 2004;30(2):153-164.
2. Cianchetti M, Mancuso AA, Amdur RJ, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope. 2009;119(12):2348-2354.
3. Iganej S, Kagan R, Anderson P, et al. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse. Head Neck. 2002;24(3): 236-246.
4. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998;20(8):739-744.
5. Martin H, Morfit HM. Cervical lymph node metastasis as the first symptom of cancer. Surg Gynecol Obstet. 1944;78:133-159.
6. Haas I, Hoffmann TK, Engers R, Ganzer U. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol. 2002;259(6):325-333.
7. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg. 1997;26(2):112-115.
8. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer. 1999;35(7):1076-1082.
9. Safa AA, Tran LM, Rege S, et al The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am. 1999;5(4):214-218.
10. Regelink G, Brouwer J, de Bree R, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging. 2002;29(8):1024-1030.
11. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49(3):480-508.
12. Miller FR, Hussey D, Beeram M, Eng T, McGuff HS, Otto RA. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131(7):626-629.
13. Pattani KM, Goodier M, Lilien D, Kupferman T, Caldito G, Nathan CO. Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan. Ear Nose Throat J. 2011;90(8):16-20.
14. Holsinger FC, Sweeney AD, Jantharapattana K, et al. The emergence of endoscopic head and neck surgery. Curr Oncol Rep. 2010;12(3):216-222.
15. Karni RJ, Rich JT, Sinha P, Haughey BH. Transoral lasermicrosurgery: a new approach for unknown primaries of the head and neck. Laryngoscope. 2011;121(6):1194-1201.
16. Oen AL, de Boer MF, Hop WC, Knegt P. Cervical metastasis from the unknown primary tumor. Eur Arch Otorhinolaryngol. 1995;252(4):222-228.
17. Koivunen P, Laranne J, Virtaniemi J, et al. Cervical metastasis of unknown origin: a series of 72 patients. Acta Otolaryngol. 2002;122(5): 569-574.
18. Koch WM, Bhatti N, Williams MF, Eisele DW. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001;124(3):331-333.
19. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29(6):1446-1449.
20. McQuone SJ, Eisele DW, Lee DJ, Westra WH, Koch WM. Occult tonsillar carcinoma in the unknown primary. Laryngoscope. 1998;108(11, pt 1):1605-1610.
21. Mendenhall WM, Mancuso AA, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site. Am J Otolaryngol. 2001;22(4):261-267.
22. Wong WL, Sonoda LI, Gharpurhy A, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers: an audit and review of published studies. Clin Oncol (R Coll Radiol). 2012;24(3):190-195.
23. Silva P, Hulse P, Sykes AJ, et al. Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary? J Laryngol Otol. 2007;121(2):149-153.
24. Padovani D, Aimoni C, Zucchetta P, Paluzzi A, Pastore A. 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol. 2009;266(2):267-271.
25. Wartski M, Le Stanc E, Gontier E, et al. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun. 2007;28(5): 365-371.
26. Mehta V, Johnson P, Tassler A, et al. A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope. 2013;123(1):146-151.
27. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology. 1984;152(3):749-753.
28. Hermans R. Imaging in cervical nodal metastases of unknown primary. Cancer Imaging. 2011;11(spec No. A):S9-S14.
29. de Braud F, al-Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol. 1993;20(3):273-278.
30. Schmalbach CE, Miller FR. Occult primary head and neck carcinoma. Curr Oncol Rep. 2007;9(2):139-146.
31. Boudreaux BA, Rosenthal EL, Magnuson JS, et al. Robot-assisted surgery for upper aerodigestive tract neoplasms. Arch Otolaryngol Head Neck Surg. 2009;135(4):397-401.
32. Vergez S, Lallemant B, Ceruse P, et al. Initial multi-institutional experience with transoral robotic surgery. Otolaryngol Head Neck Surg. 2012;147(3):475-481.
33. Hans S, Badoual C, Gorphe P, Brasnu D. Transoral robotic surgery for head and neck carcinomas. Eur Arch Otorhinolaryngol. 2012;269(8):1979-1984.
34. Genden EM, Desai S, Sung CK. Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck. 2009;31(3):283-289.
35. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope. 2009;119(11):2156-2164.
36. Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E. Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg. 2011;145(2):248-253.
37. O'Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope. 2006;116(8):1465- 1472.
38. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg. 2007;133(12):1220-1226.
39. Moore EJ, Olsen SM, Laborde RR, et al. Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc. 2012;87(3):219-225.
40. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011;137(11):1112-1116.
41. Weinstein GS, O'Malley BW Jr, Magnuson JS, et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope. 2012;122(8):1701-1707.